Delcath Systems Inc (DCTH)

[Rapture2020]

Near term? Ok; sure. But at this point, it’s just pennies.

If CHEMSAT 2.0 is the real deal, all the conversion in the world won’t matter.
Not one single bit. But first, let’s see what the interim safety analysis report brings.


DCTH has arrived at the inflection point: singe the FDA denial in 2013 through this monumental clusterfk of a 350:1 reverse split, stakes could not be higher.

DCTH has chewed up and spit out many investors. I know this is an incredibly speculative play and if I’m wrong, I’m going to get creamed.

I cannot explain why, even after this precipitous drop, I’m not concerned about my investment.

I’m in for the long game. I think everything is going to be just fine.